Current antiretroviral therapy

Alex P. Salam, Anton L. Pozniak

Source: Eur Respir Monogr 2014; 66: 12-25

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Alex P. Salam, Anton L. Pozniak. Current antiretroviral therapy. Eur Respir Monogr 2014; 66: 12-25

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Timing of concurrent highly active antiretroviral therapy (HAART) in adults with tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 302s
Year: 2006

First-line therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Improvement of HIV-related pulmonary hypertension after the introduction of an antiretroviral therapy
Source: Eur Respir J 2009; 34: 277-278
Year: 2009

What happens to pneumocystis prophylaxis use when antiretroviral therapy is widely available?
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Combination therapy in the era of immunotherapy
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019

Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021

Quality of sleep and psychiatric parameters in patients with HIV infection on highly active antiretroviral therapy (HAART)
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

Long-term antibiotic therapy
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017

Novel drug regimens against MDR-TB
Source: International Congress 2016 – The problem of multidrug-resistant tuberculosis
Year: 2016

Better diagnostics for targeted antibiotic therapy
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020

Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007

New anti-tuberculosis drugs and regimens: 2015 update
Source: ERJ Open Res 2015; 1: 00010-2015
Year: 2015

Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy
Source: Eur Respir Monogr 2021; 90: 97-117
Year: 2021

Early dosing schedules of pyrazinamide-containing anti-TB treatment have no significant impact on drug-induced hepatitis
Source: ISSN=ISSN 1810-6838, ISBN=, page=69
Year: 2007

Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis
Source: Eur Respir J 2006; 28: Suppl. 50, 128s
Year: 2006

Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART
Source: Breathe 2008; 5: 274
Year: 2009

Unmasking tuberculosis in the era of antiretroviral treatment
Source: Eur Respir J 2012; 39: 1064-1075
Year: 2012